NEW YORK (360Dx) – British diagnostics firm Owlstone Medical announced today that it has signed an agreement to provide breath biomarker services to 4D Pharma to assist with its drug-development efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.